Przyklenk K, Simkhovich B Z, Bauer B, Kloner R A
Heart Institute, Hospital of the Good Samaritan, Los Angeles, California.
Basic Res Cardiol. 1994 May-Jun;89(3):260-9. doi: 10.1007/BF00795618.
Numerous studies have described a progressive deterioration in resting myocardial blood flow following relief of sustained ischemia in both necrotic and salvaged myocardium (termed "no reflow" and "low reflow", respectively). We sought to determine whether release of the potent vasoconstrictor peptide endothelin-1 may play a role in these phenomena. As part of a previous study in our laboratory, 14 anesthetized open-chest dogs underwent 1 h of coronary artery occlusion and 4 h of reperfusion, while 2 dogs served as time-matched sham-operated controls (artery isolated but not occluded). Regional myocardial blood flow was measured by injection of radiolabeled microspheres at 30 min and 4 h post reflow; endothelin-1 concentrations in the coronary sinus were determined by radioimmunoassay at baseline, during coronary occlusion and at 30 min and 4 h after reperfusion; and the extent of myocardial necrosis was delineated by post-mortem tetrazolium staining. As expected, in dogs subjected to ischemia/reperfusion, regional myocardial blood flow deteriorated between 30 min and 4 h post reflow in both the subendocardium (1.40 +/- 0.30 versus 0.48 +/- 0.06 ml/min/g; p = 0.003; reflecting a mixture of no reflow and low reflow) and subepicardium (0.84 +/- 0.08 versus 0.64 +/- 0.07 ml/min/g; p = 0.03; due to low reflow). However, endothelin levels showed only a modest and nonsignificant increase during the protocol (4.1 +/- 0.5, 4.7 +/- 0.2 and 4.9 +/- 0.6 pg/ml plasma at baseline, 30 min and 4 h post reflow; p = NS), and regression analysis revealed no correlation between release of endothelin and deterioration in blood flow in either myocardial layer. Moreover, the sham-operated controls showed a similar modest increase in endothelin levels, with no change in myocardial perfusion during the course of the protocol. We therefore conclude that deterioration in myocardial blood flow following relief of sustained ischemia in the anesthetized open-chest dog is not associated with release of endothelin-1 into the coronary sinus.
众多研究描述了在坏死心肌和存活心肌中持续缺血缓解后静息心肌血流的渐进性恶化(分别称为“无复流”和“低复流”)。我们试图确定强效血管收缩肽内皮素-1的释放是否在这些现象中起作用。作为我们实验室先前一项研究的一部分,14只麻醉开胸犬接受了1小时冠状动脉闭塞和4小时再灌注,而2只犬作为时间匹配的假手术对照(动脉分离但未闭塞)。在再灌注后30分钟和4小时通过注射放射性标记微球测量局部心肌血流;通过放射免疫测定法在基线、冠状动脉闭塞期间以及再灌注后30分钟和4小时测定冠状窦中的内皮素-1浓度;通过死后四氮唑染色描绘心肌坏死范围。正如预期的那样,在经历缺血/再灌注的犬中,心内膜下层(1.40±0.30对0.48±0.06 ml/min/g;p = 0.003;反映无复流和低复流的混合情况)和心外膜下层(0.84±0.08对0.64±0.07 ml/min/g;p = 0.03;由于低复流)的局部心肌血流在再灌注后30分钟至4小时之间恶化。然而,内皮素水平在实验过程中仅显示出适度且无统计学意义的增加(再灌注后基线、30分钟和4小时时血浆中分别为4.1±0.5、4.7±0.2和4.9±0.6 pg/ml;p =无显著性差异),回归分析显示内皮素释放与任一心肌层血流恶化之间无相关性。此外,假手术对照显示内皮素水平有类似的适度增加,在实验过程中心肌灌注无变化。因此,我们得出结论,麻醉开胸犬持续缺血缓解后心肌血流的恶化与内皮素-1释放到冠状窦中无关。